Stevens First Principles Investment Advisors’s Biogen BIIB Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-500	Closed	-$146K	–	179
2015 Q3	$146K	Buy	+500	New	+$165K	0.12%	76
2015 Q2	–	Sell	-400	Closed	-$169K	–	225
2015 Q1	$169K	Buy	+400	New	+$158K	0.11%	87
2014 Q2	–	Sell	-150	Closed	-$46K	–	217
2014 Q1	$46K	Buy	+150	New	+$47.6K	0.03%	140

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stevens First Principles Investment Advisors's BIIB Position: Q4 2015 in Review

Stevens First Principles Investment Advisors sold out of Biogen (BIIB) in Q4 2015, closing a stake of 500 shares — an estimated $146K sold.

Stevens First Principles Investment Advisors first reported a position in BIIB in Q1 2014 and held it in 3 quarters. The position peaked at $169K in Q1 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

Stevens First Principles Investment Advisors reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
Stevens First Principles Investment Advisors sold 500 Biogen shares in Q4 2015, an estimated $146K.
Stevens First Principles Investment Advisors first reported a position in Biogen in Q1 2014 and held it in 3 quarters.
Stevens First Principles Investment Advisors's Biogen position peaked at $169K in Q1 2015.
970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q4 2015, filed 29 Jan 2016.